Deguelin, a Novel Anti-Tumorigenic Agent in Human Esophageal Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Deguelin, a Novel Anti-Tumorigenic Agent in Human Esophageal Squamous Cell Carcinoma

Published:2017-12 Issue: Volume:26 Page:10
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Baba Yuh,Kato Yasumasa

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference8 articles.

1. Deguelin induces apoptosis by targeting both EGFR-Akt and IGF1R-Akt pathways in head and neck squamous cell cancer cell lines;Baba;Biomed. Res. Int.,2015

2. Effects of deguelin on the proliferation and apoptosis of human esophageal cancer cell Ec-109: an experimental research;Bai;Zhongguo Zhong Xi Yi Jie He Za Zhi,2013

3. The MET/AXL/FGFR inhibitor S49076 impairs aurora B activity and improves the antitumor efficacy of radiotherapy;Clémenson;Mol. Cancer Ther.,2017

4. Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck;Hoellein;Oncotarget,2011

5. Regulating expressions of cyclin D1, pRb, and anti-cancer effects of deguelin on human Burkitt's lymphoma Daudi cells in vitro;Liu;Acta Pharmacol. Sin.,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway;Cancer Management and Research;2024-05

2. Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway;Acta Pharmaceutica;2024-03-01

3. Natural essential oils as a new therapeutic tool in colorectal cancer;Cancer Cell International;2022-12-13

4. Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview;Cancer Cell International;2022-08-08

5. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients;Briefings in Bioinformatics;2021-04-13